APA Practice Guidelines
III. Special Clinical Features Influencing the Bipolar Treatment Plan
A. Psychiatric Features
1. Psychosis
Psychotic symptoms (e.g., delusions, hallucinations) are commonly seen during
episodes of either mania or depression but are more common in the former,
appearing in over one-half of
manic episodes. Mood-congruent features during a
manic episode probably are not predictive of a poorer outcome, although early
onset (before age 21) of psychotic mania may predict a more severe disorder.
Mood-incongruent features have been identified in some but not all studies to be
a predictor of a shorter time in remission. The presence of psychotic features
during a manic episode may not require an
antipsychotic medication, although
most clinicians prescribe them in addition to a maintenance agent.
2. Catatonia
Catatonic features may develop in up to one-third of patients during a manic
episode. The most commonly observed symptoms of catatonia in mania are motor
excitement, mutism, and stereotypic movements. Because catatonic symptoms are
seen in other psychiatric and neurological disorders, a careful assessment is
indicated for an accurate diagnosis. In addition, patients who exhibit catatonic
stupor may go on to show more typical signs and symptoms of mania during the
same episode of illness. The presence of catatonic features during the course of
a manic episode is associated with greater episode severity, mixed states, and
somewhat poorer short-term outcomes. In treating catatonia, neuroleptics have
generally exhibited poor efficacy. In contrast, prospective studies have
demonstrated the efficacy of lorazepam in the treatment of catatonic syndromes,
including those associated with mania. Since ECT is probably the most effective
treatment for catatonic syndromes regardless of etiology, ECT should be
considered if benzodiazepines do not result in symptom resolution.
3. Risk of suicide, homicide, and violence
Like those suffering from major depression, patients with bipolar disorder
are at high risk for suicide. The frequency of suicide attempts appears similar
for the bipolar I and bipolar II subtypes. Individuals with bipolar disorder
repeatedly have been shown to have greater overall mortality than the general
population. Although much of this risk reflects the higher rate of suicide,
cardiovascular and pulmonary mortality among patients with untreated bipolar
disorder is also high.
Known general risk factors for suicide also apply to patients with bipolar
disorder. These include a history of suicide attempts, suicidal ideation,
co-morbid substance abuse, co-morbid personality disorders, agitation, pervasive
insomnia, impulsiveness, and family history of suicide. Among the phases of
bipolar disorder, depression is associated with the highest suicide risk,
followed by mixed states and presence of psychotic symptoms, with episodes of
mania being least associated with suicide. Suicidal ideation during mixed states
has been correlated with the severity of depressive symptoms. In general, a
detailed evaluation of the individual patient is necessary to assess suicidal
risk. Judgment of suicidal risk is inherently imperfect; therefore, risks and
benefits of intervention should be carefully weighed and documented.
Long-term treatment with lithium has been associated with reduction of
suicide risk. Whether this reflects an anti-impulsivity factor beyond lithium's
mood-stabilizing effect is not yet clear. Lithium may also diminish the greater
mortality risk observed among bipolar disorder patients from causes other than
suicide. It is unknown whether prolonged survival is also seen with the
anticonvulsant maintenance agents.
Clinical experience attests to the presence of violent behavior in some
patients with bipolar disorder, and violence may be an indication for
hospitalization. Co-morbid substance abuse and psychosis may contribute to the
threat of criminal violence or aggression.
continue: Substance Use Disorders
top .
pages 1 2
3
4
5
6 .
send to friend .
bipolar site
map
Written 4/02. Reviewed: 03/2006
|
|